Judah Frommer
Stock Analyst at Morgan Stanley
(0.97)
# 3,953
Out of 5,044 analysts
500
Total ratings
47.3%
Success rate
-1.1%
Average return
Main Sectors:
Stocks Rated by Judah Frommer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGMB AgomAb Therapeutics NV | Rated: Buy | $28 | $9.08 | +208.37% | 13 | Oct 5, 2026 | |
| LKFT Lakefront Biotherapeutics NV | Rated: Hold | $26 | $29.73 | -12.55% | 59 | Oct 5, 2026 | |
| ABVX ABIVAX Société Anonyme | Reiterated: Buy | $180 | $88.15 | +104.20% | 9 | Sep 28, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Hold | n/a | $13.33 | - | 15 | Sep 28, 2026 | |
| CLDX Celldex Therapeutics | Rated: Buy | $50 → $57 | $29.89 | +90.70% | 13 | Sep 23, 2026 | |
| ATTO Attovia Therapeutics | Rated: Buy | $39 | $16.21 | +140.59% | 2 | Sep 3, 2026 | |
| QTTB Q32 Bio | Initiated Coverage: Buy | $34 | $8.34 | +307.67% | 1 | Aug 24, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $18 | $8.07 | +123.05% | 22 | Aug 24, 2026 | |
| BLTE Belite Bio | Reiterated: Buy | $201 → $206 | $154.49 | +33.34% | 3 | Aug 17, 2026 | |
| ZBIO Zenas BioPharma | Reiterated: Hold | $22 → $32 | $27.26 | +17.39% | 12 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $53 → $57 | $25.76 | +121.27% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $17.50 | +111.43% | 19 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $1.73 | - | 10 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 | $2.36 | +493.22% | 4 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $19 | $9.46 | +100.85% | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $1.74 | +72.41% | 15 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 | $6.25 | +316.00% | 9 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $23 | $13.19 | +74.37% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 | $37.07 | -5.58% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $34 → $38 | $26.58 | +42.96% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $18 | $12.00 | +50.00% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $119 → $135 | $112.40 | +20.11% | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 → $104 | $64.70 | +60.74% | 27 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $104 → $119 | $112.79 | +5.51% | 14 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $141 → $139 | $17.85 | n/a | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $138 | $0.0002 | n/a | 9 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.24 | n/a | 8 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.5702 | n/a | 8 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $24.74 | n/a | 7 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $22 | $21.58 | n/a | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $9.94 | n/a | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $13 | $2.14 | n/a | 4 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $11 → $8 | $3.77 | n/a | 9 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $55 | $22.59 | n/a | 6 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $46 | $100.60 | n/a | 3 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3.5 | $31.73 | n/a | 1 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $24 | $97.43 | n/a | 7 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 → $26 | $65.14 | n/a | 10 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $12.19 | n/a | 2 | Jul 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $90 → $95 | $85.33 | n/a | 10 | Jul 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $328 | $946.92 | n/a | 6 | Jul 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 | $61.64 | n/a | 28 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 → $116 | $214.73 | n/a | 9 | Jun 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €22.00 → €24.00 | €32.28 | n/a | 3 | Jun 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $98 → $107 | $118.64 | n/a | 19 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $154 → $178 | $127.23 | n/a | 10 | May 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $38 | $98.58 | n/a | 4 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $67 → $63 | $78.14 | n/a | 17 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $94.88 | n/a | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.57 | n/a | 1 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $36.32 | n/a | 1 | Mar 6, 2019 |
AgomAb Therapeutics NV
Oct 5, 2026
Rated: Buy
Price Target: $28
Current: $9.08
Upside: +208.37%
Lakefront Biotherapeutics NV
Oct 5, 2026
Rated: Hold
Price Target: $26
Current: $29.73
Upside: -12.55%
ABIVAX Société Anonyme
Sep 28, 2026
Reiterated: Buy
Price Target: $180
Current: $88.15
Upside: +104.20%
4D Molecular Therapeutics
Sep 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $13.33
Upside: -
Celldex Therapeutics
Sep 23, 2026
Rated: Buy
Price Target: $50 → $57
Current: $29.89
Upside: +90.70%
Attovia Therapeutics
Sep 3, 2026
Rated: Buy
Price Target: $39
Current: $16.21
Upside: +140.59%
Q32 Bio
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $8.34
Upside: +307.67%
REGENXBIO
Aug 24, 2026
Reiterated: Buy
Price Target: $18
Current: $8.07
Upside: +123.05%
Belite Bio
Aug 17, 2026
Reiterated: Buy
Price Target: $201 → $206
Current: $154.49
Upside: +33.34%
Zenas BioPharma
Aug 17, 2026
Reiterated: Hold
Price Target: $22 → $32
Current: $27.26
Upside: +17.39%
Aug 13, 2026
Rated: Buy
Price Target: $53 → $57
Current: $25.76
Upside: +121.27%
Aug 12, 2026
Reiterated: Buy
Price Target: $37
Current: $17.50
Upside: +111.43%
Aug 12, 2026
Reiterated: Sell
Price Target: n/a
Current: $1.73
Upside: -
Aug 12, 2026
Rated: Buy
Price Target: $14
Current: $2.36
Upside: +493.22%
Aug 11, 2026
Rated: Buy
Price Target: $20 → $19
Current: $9.46
Upside: +100.85%
Aug 11, 2026
Reiterated: Hold
Price Target: $3
Current: $1.74
Upside: +72.41%
Aug 10, 2026
Rated: Buy
Price Target: $26
Current: $6.25
Upside: +316.00%
Aug 10, 2026
Rated: Buy
Price Target: $20 → $23
Current: $13.19
Upside: +74.37%
Aug 7, 2026
Reiterated: Hold
Price Target: $35
Current: $37.07
Upside: -5.58%
Aug 6, 2026
Rated: Buy
Price Target: $34 → $38
Current: $26.58
Upside: +42.96%
Aug 6, 2026
Reiterated: Buy
Price Target: $17 → $18
Current: $12.00
Upside: +50.00%
Aug 6, 2026
Rated: Buy
Price Target: $119 → $135
Current: $112.40
Upside: +20.11%
Jul 31, 2026
Reiterated: Buy
Price Target: $93 → $104
Current: $64.70
Upside: +60.74%
Jul 29, 2026
Reiterated: Hold
Price Target: $104 → $119
Current: $112.79
Upside: +5.51%
Aug 3, 2023
Reiterated: Hold
Price Target: $141 → $139
Current: $17.85
Upside: n/a
Jun 5, 2023
Reiterated: Buy
Price Target: $138
Current: $0.0002
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $13
Current: $4.24
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $40
Current: $0.5702
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $28
Current: $24.74
Upside: n/a
Apr 3, 2023
Reiterated: Buy
Price Target: $21 → $22
Current: $21.58
Upside: n/a
Mar 31, 2023
Reiterated: Buy
Price Target: $8 → $7
Current: $9.94
Upside: n/a
Mar 28, 2023
Reiterated: Buy
Price Target: $16 → $13
Current: $2.14
Upside: n/a
Mar 9, 2023
Downgraded: Hold
Price Target: $11 → $8
Current: $3.77
Upside: n/a
Feb 28, 2023
Reiterated: Buy
Price Target: $51 → $55
Current: $22.59
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $57 → $46
Current: $100.60
Upside: n/a
May 11, 2022
Reiterated: Sell
Price Target: $3.5
Current: $31.73
Upside: n/a
Aug 4, 2020
Reiterated: Buy
Price Target: $23 → $24
Current: $97.43
Upside: n/a
Jul 30, 2020
Reiterated: Hold
Price Target: $22 → $26
Current: $65.14
Upside: n/a
Jul 27, 2020
Reiterated: Buy
Price Target: $18
Current: $12.19
Upside: n/a
Jul 22, 2020
Rated: Hold
Price Target: $90 → $95
Current: $85.33
Upside: n/a
Jul 8, 2020
Reiterated: Hold
Price Target: $328
Current: $946.92
Upside: n/a
Jun 18, 2020
Reiterated: Hold
Price Target: $35
Current: $61.64
Upside: n/a
Jun 10, 2020
Rated: Buy
Price Target: $125 → $116
Current: $214.73
Upside: n/a
Jun 3, 2020
Reiterated: Hold
Price Target: €22.00 → €24.00
Current: €32.28
Upside: n/a
May 28, 2020
Rated: Buy
Price Target: $98 → $107
Current: $118.64
Upside: n/a
May 22, 2020
Reiterated: Hold
Price Target: $154 → $178
Current: $127.23
Upside: n/a
May 21, 2020
Rated: Buy
Price Target: $31 → $38
Current: $98.58
Upside: n/a
May 5, 2020
Rated: Buy
Price Target: $67 → $63
Current: $78.14
Upside: n/a
May 4, 2020
Reiterated: Buy
Price Target: $39
Current: $94.88
Upside: n/a
Mar 6, 2020
Downgraded: Hold
Price Target: n/a
Current: $15.57
Upside: n/a
Mar 6, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $36.32
Upside: n/a